Next-generation biopharmaceuticals

Unicenta

A highly purified placental recovery product
from South Korea. Systemic revitalization of the body
and support for hormonal balance.

Learn more about the product
Challenges

Your body deserves more

As we age, the body's biological resources become depleted. This is a natural process, but it can be slowed down and guided in the right direction.

Chronic fatigue

Persistent tiredness and reduced energy and performance that do not go away after rest.

Hormonal imbalance

Menopausal changes, sleep disturbances, emotional instability, and a reduced quality of life.

Age-related changes

Loss of skin firmness, slower tissue regeneration, and weakened immune defenses.

Scientific foundation

The science of placental recovery

Unicenta Inj. 2mL is not just an extract, but a highly purified biopharmaceutical product officially approved by South Korea's MFDS. Each ampoule contains a concentrate of low-molecular-weight peptides and amino acids obtained through multi-stage hydrolysis.

2 mLAmpoule volume
100%Active ingredient
2014Year of licensing
PIC/SManufacturing standard
Manufacturing in South Korea
Expert opinion

Why do experts choose Unicenta?

Unicenta is a legal medicinal product with official status in South Korea. Its safety is confirmed by the international CoPP certificate, allowing it to be used in leading clinics around the world.

Unimed PharmaceuticalsOsong, South Korea
EU-GMPCertificate
US FDAAudit
CoPPInternational
Benefits

Why Unicenta?

Cellular recovery

Low-molecular-weight peptides penetrate to the cellular level, triggering the natural regeneration of tissues.

Viral safety

Multi-stage donor screening, nanofiltration, and thermal inactivation ensure absolute safety.

Standardized composition

The content and biological activity of every ampoule are strictly controlled, ensuring a stable result.

Clinical evidence

More than 10 years of clinical use and strict post-marketing surveillance in South Korea.

Hormonal balance

Support for the body during menopausal changes: normalization of sleep, energy, and emotional well-being.

Government control

Every batch undergoes National Lot Release, a government quality inspection before reaching clinics.

Quality control

Above global standards

Every batch of Unicenta undergoes National Lot Release, a government quality inspection in MFDS laboratories before reaching clinics. 100% viral safety: from multi-stage screening to nanofiltration and thermal virus inactivation.

National Lot Release

Every batch of Unicenta undergoes National Lot Release, a government quality inspection in MFDS laboratories before reaching clinics.

100% viral safety

From multi-stage screening to nanofiltration and thermal virus inactivation — a complete protection cycle.

Standardized composition

The content and biological activity of every ampoule are strictly standardized, eliminating the risk of allergies and guaranteeing a stable therapeutic result.

Documentation

FDA (NAI) 2023
Registration Document Unicenta
Unicenta Inj Extract
Unicenta Unique
Additional document
Certificate of registration
GMP Certificate (KOR)
GMP Certificate (Asan)

Library

Menopausal disorders
Menopausal disorders
Comparative analysis
Comparative analysis
Epicondylitis
Epicondylitis
Hyperpigmentation
Hyperpigmentation
Chronic fatigue
Chronic fatigue
Ligament injuries
Ligament injuries
HPE and cell therapy
HPE and cell therapy
Questions and answers

Frequently asked questions

Unicenta Inj. 2mL is a highly purified biopharmaceutical product based on human placental hydrolysate, manufactured in South Korea. It contains low-molecular-weight peptides and amino acids intended for systemic recovery of the body at the cellular level.

The product was developed for patients in need of deep revitalization — for chronic fatigue, hormonal imbalance, age-related skin changes, and during menopausal changes. It is especially effective for women over 35.

Yes. Every batch undergoes National Lot Release, a government quality inspection in South Korea's MFDS laboratories. 100% viral safety is ensured, from multi-stage donor screening to nanofiltration and thermal virus inactivation.

Unicenta has an international CoPP (Certificate of Pharmaceutical Product), approval from South Korea's MFDS, and is manufactured at facilities certified to EU-GMP standards with a confirmed US FDA audit.

The product is administered by injection (intramuscularly or subcutaneously) as prescribed by a doctor. It is supplied as a solution in 2 mL ampoules. The course and dosage are determined individually by a specialist.

Unlike questionable alternatives, Unicenta is a legal medicinal product with more than 10 years of clinical use, a transparent composition, proven effectiveness, and government control at every stage of production.

Start today

Ready to restore
your biological resources?

Contact us for a detailed consultation on the use of Unicenta Inj. 2mL and the terms of cooperation.